Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Weight management

Recent news which mentions Weight management

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Weight management Business Pharmaceuticals
From CNBC.com News
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Tags Breaking News: Technology Hims & Hers Health Inc Health & Science
From CNBC.com News
If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
Tags Make It / Money Stock markets Make It / Save and Invest
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags stocks Mondelez International Inc Stock markets
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Weight management Business Health insurance
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Business News Renter's insurance Health & Science
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Herbalife Ltd WW International Inc Novo Nordisk A/S
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Drug trials Diabetes Health care industry
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Social issues Employee benefits Employee healthcare benefits
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Business News Health & Science Biotechnology
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Eli Lilly and Co Health care industry Roche Holding AG
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Pfizer Inc Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Health & Science Breaking News: Earnings Business News
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Health care industry Alphabet Inc Enterprise
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Investing Breaking News: Investing Fast Money
From CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Diabetes Health care industry Eli Lilly and Co
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
Tags Business News Health & Science Social issues
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Tags Addiction and substance abuse Breaking news Business
From CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
Tags Business News Health & Science Social issues
From CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Tags Medication Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Tags Science Weight management Business
From CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Tags Health insurance Obesity Business
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Clinical trials
From CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Europe News
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Obesity Science Pharmaceuticals
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags Science Weight management Breaking news
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Business News Health & Science Social issues
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Surgical procedures Pharmaceuticals Weight management
From CNBC.com News
TikTokers say berberine is 'nature's Ozempic': Here's what doctors want you to know about the buzzy supplement
Tags Medication Health Tips and Wellness Advice Make It / Life
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.